Genomics Meets Artificial Intelligence
The bioinformatics platform integrates genomic sequencing, biomarker data, and molecular profiles with clinical records to build a complete biological picture of each patient.
This enables recommendations based not only on the diagnosis, but on what will genuinely work for this patient's specific genetic and molecular profile.
- Whole-genome and exome analysis with variant interpretation
- Pharmacogenomic prediction of drug metabolism
- Somatic mutation identification for cancer treatment matching
- Polygenic risk scoring for hereditary disease prevention
Precision Medicine in Practice
Precision medicine moves beyond one-size-fits-all protocols. MET-Ai integrates genomic, microbiome, proteomic, and clinical dimensions to generate personalised treatment pathways.
The result is less trial and error, fewer adverse reactions, and patients reaching effective treatment more quickly and with fewer side effects.
- Precision oncology that matches tumour mutations to therapies
- Rare-disease diagnosis through phenotype-to-genotype matching
- Antibiotic-resistance profiling from microbial sequencing
- Gene-drug interaction checking before any new medication
Applications in Clinical Practice
Matching of tumour mutations to the most effective targeted therapy.
Identification of rare genetic disorders through genomic analysis.
Prevention of adverse reactions through metabolism compatibility testing.
Tracking of pathogen evolution and antibiotic resistance.
Identification of genetic risk to enable early intervention.
Use of anonymised genomic data to accelerate discovery.
Deploy Bioinformatics AI in Your Hospital
Contact Eeswar Makineni to explore how this capability can transform your hospital.